Lv, D., Zhang, Y., Kim, H., Zhang, L., & Ma, X. (2013). CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Nature Publishing Group.
シカゴスタイル引用形Lv, Dandan, Yan Zhang, Ha-Jeong Kim, Lixing Zhang, , Xiaojing Ma. CCL5 As a Potential Immunotherapeutic Target in Triple-negative Breast Cancer. Nature Publishing Group, 2013.
MLA引用形式Lv, Dandan, et al. CCL5 As a Potential Immunotherapeutic Target in Triple-negative Breast Cancer. Nature Publishing Group, 2013.
警告: この引用は必ずしも正確ではありません.